Pharma Project India GSK to Build Pharmaceutical Manufacturing Facility

Editor: Dominik Stephan

Glaxo Smith Kline (GSK) has recently announced its plan to build a new factory. For this upcoming facility the company is expected to invest Rs. 864 crore. The company will partner with local design and construction companies to build a state-of-the-art manufacturing facility which is expected to benefit from leading edge technologies including continuous manufacturing and automated systems.

Related Companies

Glaxo Smith Kline to build pharma plant in India
Glaxo Smith Kline to build pharma plant in India
(Picture: PROCESS)

Mumbai/India - When complete, the new factory will make pharmaceutical products for the Indian market at a rate of up eight billion tablets and one billion capsules a year. The facility, expected to be operational by 2017, will also include a warehouse, site infrastructure and utilities to support the manufacturing and packing of the medicines.